Target Estradiol Level for Transgender Men on Testosterone Therapy
For transgender men receiving testosterone therapy, estradiol levels should be maintained at less than 50 pg/mL during the first 6 months of treatment or until amenorrhea is achieved for 6 months. 1
Monitoring Protocol
The Endocrine Society Clinical Practice Guideline explicitly states that estradiol levels should be measured during the first 6 months of testosterone treatment or until there has been no uterine bleeding for 6 months, with target levels below 50 pg/mL 1. This represents the clearest guideline-based recommendation for estradiol monitoring in this population.
Key Monitoring Points:
- Timing: Check estradiol every 2-3 months during the first 6 months of testosterone therapy
- Target: Estradiol <50 pg/mL
- Duration: Continue monitoring until amenorrhea is sustained for 6 months
- After initial period: Once amenorrhea is established and estradiol is suppressed, routine estradiol monitoring may not be necessary
What Actually Happens with Testosterone Treatment
Recent research demonstrates that testosterone therapy actually decreases estradiol levels in transgender men rather than increasing them 2. A 2018 study following transgender men for up to 6 years found that:
- Estradiol levels significantly decreased with testosterone treatment
- Final estradiol levels remained within the normal male range (typically 10-40 pg/mL)
- There is a negative correlation between testosterone levels and body mass index, which may explain part of the estradiol decline through reduced fat mass 2
Clinical Implications:
There is no role for aromatase inhibitors or other estrogen-reducing strategies in transgender men on testosterone therapy 2. The concern that testosterone would be aromatized to excessive estrogen has not been supported by clinical data.
Common Pitfalls to Avoid
- Do not assume testosterone will increase estradiol: The opposite occurs—testosterone suppresses estradiol production from the ovaries
- Do not prescribe aromatase inhibitors: These are unnecessary and not supported by evidence 2
- Do not continue routine estradiol monitoring indefinitely: After the initial 6-month period and achievement of amenorrhea, focus shifts to testosterone level monitoring 1
Testosterone Monitoring Takes Priority
After the initial estradiol monitoring period, the primary focus should be maintaining testosterone levels in the normal physiological male range (300-1,000 ng/dL or 350-700 ng/dL depending on injection timing) 1, 3. Testosterone should be measured every 2-3 months until stable, then 1-2 times yearly.